RPG Life Sciences Q1 FY2026 PAT slips to Rs. 26.29 Cr
Cipla reports Q1 FY2025-26 consolidated profit up at Rs. 1,297.62 Cr
Solara Active Pharma Sciences consolidated Q1FY26 PAT rises to Rs. 10.52 Cr
Laurus Labs consolidated Q1 FY2026 PAT at Rs. 163.02 Cr
Pfizer completes licensing agreement with 3SBio to expand oncology portfolio
Dr Reddy's Laboratories reports 2% rise in Q1 net profit to Rs. 1,418 Cr
Zydus receives tentative approval from USFDA for Ibrutinib tablets
Lupin receives USFDA approvals for Liraglutide and Glucagon injectable products
NATCO Pharma API unit in Mekaguda receives EIR from USFDA
48 projects approved under PLI Scheme for promotion of domestic manufacturing of critical KSMs/DIs/APIs
This GMP certification for our sterile drug product manufacturing facility, Goa Plant II is a testament to our relentless efforts to supply quality and affordable medicines across geographies
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
